Article Contents ::
- 1 Details About Generic Salt :: Risedron
- 2 Main Medicine Class:: Hormones,bisphosphonates
- 3 (riss-ED-row-nate) Actonel Class: Hormones/bisphosphonates
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Risedron
Main Medicine Class:: Hormones,bisphosphonates
(riss-ED-row-nate)
Actonel
Class: Hormones/bisphosphonates
Drugs Class ::
Action Inhibits normal and abnormal bone resorption.
Indications for Drugs ::
Indications Treatment of osteoporosis in postmenopausal women; prevention of osteoporosis in postmenopausal women at risk of developing osteoporosis; prevention and treatment of glucocorticoid-induced osteoporosis in men and women; treatment of Paget’s disease of the bone.
Drug Dose ::
Route/Dosage
Paget’s Disease
ADULTS: PO 30 mg once daily for 2 months.
Treatment and Prevention of Postmenopausal Osteoporosis; Glucocorticoid-Induced Osteoporosis
ADULTS: PO 5 mg/day.
Contraindication ::
Contraindications Hypocalcemia.
Drug Precautions ::
Precautions
Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy not established. Renal function impairment: Not recommended in patients with CrCl < 30 mL/min.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CNS: Headache; dizziness. DERM: Rash. EENT: Amblyopia; tinnitus; dry eye; sinusitis. GI: Diarrhea; abdominal pain; nausea; constipation; belching; colitis; dysphagia; esophagitis; esophageal ulcers; gastric ulcer. RESP: Bronchitis. OTHER: Flu syndrome; chest pain; asthenia; neoplasm; arthralgia; bone pain; leg cramps; myasthenia; peripheral edema.
Drug Mode of Action ::
Action Inhibits normal and abnormal bone resorption.
Drug Interactions ::
Interactions
Antacids, calcium supplements, oral medicines containing divalent cations: Decrease risedronate absorption, which may decrease activity.
Drug Assesment ::
Assessment/Interventions
- Obtain a complete history of prescription and nonprescription drugs and any history of hypersensitivities.
- Assess for possible drug interactions and potential adverse reactions.
- Ensure that hypocalcemia or other disturbance of the bone and mineral metabolism are effectively treated before administration of risedronate.
- Monitor for signs and symptoms of upper GI disorders such as dysphagia, epigastric pain, esophagitis, esophageal ulcer, and gastric ulcer.
|
Drug Storage/Management ::
Administration/Storage
- Store at room temperature in tightly closed container.
- Administer 30 min before the first meal of the day.
- Administer in upright position with a full glass of water.
- Ensure adequate intake of calcium and vitamin D in patients with Paget’s disease.
- Administer with caution to patients with a history of upper GI disorders.
- Exercise caution when administering concomitantly with aspirin or any other NSAID medications.
Drug Notes ::
Patient/Family Education
- Instruct patient to take the medication exactly as directed, as clinical benefits may be negatively affected by failure to take the drug according to instructions.
- Instruct patient to take in an upright position with a full 8 oz glass of water ³ 30 min before the first food or liquid of the day.
- Remind patient to avoid lying down for 30 min after taking this medication.
- Instruct patient to take any supplement containing calcium or antacids containing magnesium or aluminum ³ 1 hr prior or 2 hr after taking risedronate tablets to prevent interference with absorption.
- Warn nursing mothers that a decision to use the drug or continue nursing should be made in collaboration with their primary health care provider.